Microfluidic Impedance Sensor Array With Microparticle Signal Amplification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing miniaturized impedance biosensors lack sufficient sensitivity and require bulky downstream sensors for immunoassays, hindering their development into commercially viable point-of-care diagnostic devices.
Innovation Solution
A microfluidic device with a multi-layer network and integrated impedance detection system, utilizing microparticles labeled with antibodies to enhance sensitivity, allowing for autonomous capillary flow and rapid detection of biomarkers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If miniaturized impedance biosensors are developed, then device portability and ease of operation are improved, but sensitivity for immunoassays deteriorates
Solution Approach 1:
Microparticles serve as an intermediary signal amplifier between the target analyte and the impedance sensor. The microparticles conjugated to detector antibodies bind to the analyte and accumulate on the electrode surface, providing a measurable impedance signal that bridges the gap between low analyte concentration and detectable signal requirements.
Solution Approach 2:
The invention changes the physical parameters of the sensing system by introducing microparticles with specific size (1-10 μm) and electrical properties. These parameter changes enable the system to detect low concentrations of analytes through impedance measurements while maintaining miniaturized device form factor.
2Measurement precision
If sensitivity for immunoassays is improved, then detection capability is enhanced, but device complexity and bulkiness of downstream sensors increase
Solution Approach 1:
The invention merges the detection function directly into the microfluidic chip by integrating impedance electrodes with the microfluidic channel. This consolidation eliminates the need for separate, bulky downstream sensors while maintaining high sensitivity through the microparticle-enhanced impedance measurement capability.
Solution Approach 2:
The microfluidic channel itself serves the dual function of delivering reagents and enabling impedance measurement. The microfluidic network is designed to work directly with the impedance sensor, allowing the system to self-containedly perform both fluid handling and detection without requiring external bulky equipment.
3Measurement precision
If microparticles are used to enhance sensitivity, then detection limit is improved, but manufacturing precision requirements increase
Solution Approach 1:
The invention uses disposable microparticles conjugated to detector antibodies that are discarded after a single use. This approach simplifies manufacturing requirements compared to reusable sensor components, as the microparticles can be easily synthesized and conjugated without requiring high-precision manufacturing, while still achieving high detection sensitivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device achieves improved sensitivity for biomarker detection, enabling detection of low concentrations of analytes like TNF-α down to 83.46 pg/mL within 5-10 minutes, suitable for point-of-care diagnostics.
Implementation Method 1
measuring electrical impedance changes in the presence of target analytes from sinusoidal input voltages
Implementation Method 2
Capillary microfluidics have been utilized in different platforms to conduct different types of immunoassays
Data Source
AI summary
Described herein are devices and methods for improved detection and quantitation of biomolecules. Devices and methods may include a microfluidic biosensing platform for measuring electrical impedance changes in the presence of target analytes from sinusoidal input voltages to improve the sensitivity of immunoassays. In one embodiment, the described devices and methods may provide a point-of-care immunoassay platform for quantitative diagnostics using signal-enhancing microparticles to improve sensitivity and the limit-of-detection.